General Information of the Cell Line
Cell Line ID
CL000218
Cell Line Name
BT-474
Synonyms
Bt-474
BT474
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0179
Tissue Information
Breast
Disease
Invasive breast carcinoma of no special type (NCIt: C4194)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT01093, 3-phosphoinositide-dependent protein kinase 1
Compound ID Compound Name Compound Formula
CP0473312
7-methyl-2-((7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino)-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one
   Show/Hide
C18H20N8O2
 1
1
IC50 > 8300 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0002912
4-[[2-[(4-aminocyclohexyl)amino]-9-hexylpurin-6-yl]amino]phenol
   Show/Hide
C23H33N7O  1
1
GI50 = 7700 nM
   TI
   LI
   LO
   TS
CP0021627
4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-6-(pyrrolidin-1-ylmethyl)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol
   Show/Hide
C20H25N7O2  1
1
IC50 = 1250 nM
   TI
   LI
   LO
   TS
CP0024313
[2-amino-4-(trifluoromethoxy)phenyl]-[4-[7-(4-methylpiperazin-1-yl)pyrido[3,2-d]pyrimidin-4-yl]piperidin-1-yl]methanone
   Show/Hide
C25H28F3N7O2  1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0037802
4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-6-((S)-2-amino-1-phenylethoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol
   Show/Hide
C23H25N7O3  1
1
IC50 = 124 nM
   TI
   LI
   LO
   TS
CP0039472
4-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[(E)-piperidin-1-yliminomethyl]pyrimidine-4,6-diamine
   Show/Hide
C24H25FN8  1
1
IC50 = 49 nM
   TI
   LI
   LO
   TS
CP0043499
3-((S)-2-amino-3-(1H-indol-3-yl)propoxy)-5-(3-methyl-1H-pyrazolo[4,3-b]pyrazin-5-yl)-6-(2-methylfuran-3-yl)pyridin-2-amine
   Show/Hide
C27H26N8O2  1
1
IC50 = 310 nM
   TI
   LI
   LO
   TS
CP0046864
4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-6-((R)-2-amino-3-phenylpropoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol
   Show/Hide
C24H27N7O3  1
1
IC50 = 742 nM
   TI
   LI
   LO
   TS
CP0046866
4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-6-((methylamino)methyl)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol
   Show/Hide
C17H21N7O2  1
1
IC50 = 439 nM
   TI
   LI
   LO
   TS
CP0046892
4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-6-((R)-3-amino-1-phenylpropoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol
   Show/Hide
C24H27N7O3  1
1
IC50 = 224 nM
   TI
   LI
   LO
   TS
CP0048166
2-[[5-cyano-4-[2,4-dichloro-5-[2-(diethylamino)ethoxy]phenyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl]sulfanyl]-N-methylacetamide
   Show/Hide
C22H24Cl2N6O2S  1
1
GI50 = 78 nM
   TI
   LI
   LO
   TS
CP0057972
2-[[4-(2-chloro-4,5-dimethoxyphenyl)-5-cyano-7H-pyrrolo[2,3-d]pyrimidin-2-yl]sulfanyl]-N,N-dimethylacetamide
   Show/Hide
C19H18ClN5O3S  1
1
GI50 = 34 nM
   TI
   LI
   LO
   TS
CP0069884
4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(3-{[2-(4-methoxyphenyl)ethyl]amino}propoxy)-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol
   Show/Hide
C27H33N7O4  1
1
IC50 = 260 nM
   TI
   LI
   LO
   TS
CP0070350
(E)-4-(diethylamino)-1-[4-(3-ethynylanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]but-2-en-1-one
   Show/Hide
C26H27N5O2  1
1
IC50 = 550 nM
   TI
   LI
   LO
   TS
CP0088096
(2S)-2-(4-chlorophenyl)-1-[4-[(5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one
   Show/Hide
C24H32ClN5O2  1
1
IC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0095882
(2S)-1-{[6-furan-3-yl-5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxy}-3-(1H-indol-3-yl)propan-2-amine
   Show/Hide
C28H25N5O2  1
1
IC50 = 340 nM
   TI
   LI
   LO
   TS
CP0096184
(S)-1-(6-(furan-3-yl)-5-(3-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yloxy)-3-(1H-indol-3-yl)propan-2-amine
   Show/Hide
C27H24N6O2  1
1
IC50 = 300 nM
   TI
   LI
   LO
   TS
CP0122572
4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-6-((S)-3-amino-1-phenylpropoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol
   Show/Hide
C24H27N7O3  1
1
IC50 = 1 nM
   TI
   LI
   LO
   TS
CP0128025
4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-6-((dimethylamino)methyl)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol
   Show/Hide
C18H23N7O2  1
1
IC50 = 357 nM
   TI
   LI
   LO
   TS
CP0128460
3-((2S)-2-amino-3-(2-amino-5-(3-methyl-1H-pyrazolo[4,3-b]pyrazin-5-yl)-6-(2-methylfuran-3-yl)pyridin-3-yloxy)propyl)-1H-indole-2-carboxamide
   Show/Hide
C28H27N9O3  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0151263
(S)-1-(6-(furan-3-yl)-5-(3-methyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)pyridin-3-yloxy)-3-(1H-indol-3-yl)propan-2-amine
   Show/Hide
C26H23N7O2  1
1
IC50 = 640 nM
   TI
   LI
   LO
   TS
CP0151265
(S)-1-(6-(furan-3-yl)-5-(3-methyl-1H-pyrazolo[4,3-b]pyridin-5-yl)pyridin-3-yloxy)-3-(1H-indol-3-yl)propan-2-amine
   Show/Hide
C27H24N6O2  1
1
IC50 = 2100 nM
   TI
   LI
   LO
   TS
CP0163871
4-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[(E)-morpholin-4-yliminomethyl]pyrimidine-4,6-diamine
   Show/Hide
C23H23FN8O  1
1
IC50 = 31 nM
   TI
   LI
   LO
   TS
CP0206212
4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-7-(2-aminoethoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol
   Show/Hide
C17H21N7O3  1
1
IC50 = 420 nM
   TI
   LI
   LO
   TS
CP0206214
4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-7-(4-aminobutoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol
   Show/Hide
C19H25N7O3  1
1
IC50 = 700 nM
   TI
   LI
   LO
   TS
CP0244689
4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-6-(2-aminoethyl)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol
   Show/Hide
C17H21N7O2  1
1
IC50 = 1090 nM
   TI
   LI
   LO
   TS
CP0265167
3-((S)-2-amino-3-(1H-indol-3-yl)propoxy)-5-(3-methyl-1H-indazol-5-yl)-6-(2-methylfuran-3-yl)pyridin-2-amine
   Show/Hide
C29H28N6O2  1
1
IC50 = 200 nM
   TI
   LI
   LO
   TS
CP0271240
4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-6-(2-(methylamino)ethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol
   Show/Hide
C18H23N7O3  1
1
IC50 = 3190 nM
   TI
   LI
   LO
   TS
CP0274799
4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-6-(3-aminopropyl)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol
   Show/Hide
C18H23N7O2  1
1
IC50 = 3520 nM
   TI
   LI
   LO
   TS
CP0281776
2-(4-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)-6-aminopyrimidin-5-yl)methyleneamino)piperazin-1-yl)ethanol
   Show/Hide
C25H28FN9O  1
1
IC50 = 14 nM
   TI
   LI
   LO
   TS
CP0293987
4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-6-((S)-2-amino-3-phenylpropoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol
   Show/Hide
C24H27N7O3  1
1
IC50 = 1500 nM
   TI
   LI
   LO
   TS
CP0353118
(S)-1-(6-(furan-3-yl)-2-methyl-5-(3-methyl-1H-pyrazolo[4,3-b]pyrazin-5-yl)pyridin-3-yloxy)-3-(1H-indol-3-yl)propan-2-amine
   Show/Hide
C27H25N7O2  1
1
IC50 = 1260 nM
   TI
   LI
   LO
   TS
CP0432356
2-piperidin-4-ylethyl N-[4-[(1-benzylindazol-5-yl)amino]-5-ethyl-7aH-pyrrolo[2,3-d]pyrimidin-6-yl]carbamate
   Show/Hide
C30H34N8O2  1
1
IC50 = 130 nM
   TI
   LI
   LO
   TS
CP0432357
(4-amino-4-methylcyclohexyl) N-[4-[(1-benzylindazol-5-yl)amino]-5-ethyl-7aH-pyrrolo[2,3-d]pyrimidin-6-yl]carbamate
   Show/Hide
C30H34N8O2  1
1
IC50 = 130 nM
   TI
   LI
   LO
   TS
CP0433375
(E)-1-[4-(3-ethynylanilino)-8,9-dihydro-7H-pyrimido[5,4-h][1,5]benzoxazepin-6-yl]-4-piperidin-1-ylbut-2-en-1-one
   Show/Hide
C28H29N5O2  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0478189
4-(4-(cyclopentyloxy)-5-(2- methylbenzo[d]oxazol-6-yl)-7H- pyrrolo[2,3-d]pyrimidin-2- ylamino)-3-methoxy-N- methylbenzamide
   Show/Hide
C28H28N6O4  1
1
IC50 = 6970 nM
   TI
   LI
   LO
   TS
CP0494681
2-imidazol-1-ylethyl N-[4-[(1-benzylindazol-5-yl)amino]-5-ethyl-7aH-pyrrolo[2,3-d]pyrimidin-6-yl]carbamate
   Show/Hide
C28H27N9O2  1
1
IC50 = 860 nM
   TI
   LI
   LO
   TS
CP0496951
2-piperazin-1-ylethyl N-[4-[(1-benzylindazol-5-yl)amino]-5-ethyl-7aH-pyrrolo[2,3-d]pyrimidin-6-yl]carbamate
   Show/Hide
C29H33N9O2  1
1
IC50 = 71 nM
   TI
   LI
   LO
   TS
CP0499124
piperidin-2-ylmethyl N-[4-[(1-benzylindazol-5-yl)amino]-5-ethyl-7aH-pyrrolo[2,3-d]pyrimidin-6-yl]carbamate
   Show/Hide
C29H32N8O2  1
1
IC50 = 470 nM
   TI
   LI
   LO
   TS
CP0531857
(E)-1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-8,9-dihydro-7H-pyrimido[5,4-h][1,5]benzoxazepin-6-yl]-4-morpholin-4-ylbut-2-en-1-one
   Show/Hide
C32H31ClFN5O4  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0532116
(E)-1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-8,9-dihydro-7H-pyrimido[5,4-h][1,5]benzoxazepin-6-yl]-4-pyrrolidin-1-ylbut-2-en-1-one
   Show/Hide
C32H31ClFN5O3  1
1
IC50 = 172 nM
   TI
   LI
   LO
   TS
CP0558106
(E)-1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-8,9-dihydro-7H-pyrimido[5,4-h][1,5]benzoxazepin-6-yl]-4-(dimethylamino)but-2-en-1-one
   Show/Hide
C30H29ClFN5O3  1
1
IC50 = 127 nM
   TI
   LI
   LO
   TS
CP0562111
(E)-1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-(2-methylpiperidin-1-yl)but-2-en-1-one
   Show/Hide
C33H33ClFN5O3  1
1
IC50 = 127 nM
   TI
   LI
   LO
   TS
CP0562232
(E)-1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-(4-methylpiperidin-1-yl)but-2-en-1-one
   Show/Hide
C33H33ClFN5O3  1
1
IC50 = 200 nM
   TI
   LI
   LO
   TS
CP0634648
N-((R)-Cyclopropyl(pyridin-2-yl)methyl)-3-(4-((endo)-3-hydroxy-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-1H-indazole-5-carboxamide
   Show/Hide
C30H31N5O2  1
1
GI50 = 15 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Breast)
Cell Line Name Organism Disease
MX-1 Homo sapiens (Human) Breast carcinoma
HCC1954 Homo sapiens (Human) Breast ductal carcinoma
HDQ-P1 Homo sapiens (Human) Breast ductal carcinoma
SUM159PT Homo sapiens (Human) Breast pleomorphic carcinoma
HCC1806 Homo sapiens (Human) Breast squamous cell carcinoma, acantholytic variant
Hs 578T Homo sapiens (Human) Invasive breast carcinoma of no special type
BT-20 Homo sapiens (Human) Invasive breast carcinoma of no special type
BT-549 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-10A Homo sapiens (Human) -
184B5 Homo sapiens (Human) -
UFH-001 Homo sapiens (Human) -
184A1N4 Homo sapiens (Human) -